Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine in HIV-infected Adults: A Randomized Control Trial

NCT03567304 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

NCT NCT03567304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03567304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurocognitive Function Improvement After Switching From Efavirenz to Rilpivirine in HIV-infected Adults: A Randomized Control Trial
Lead sponsor
Chiang Mai University
Phase
Phase 4
Overall status
Unknown status
Start date
July 6, 2018
Completion date
July 31, 2020
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv-1-infection, neurocognitive dysfunction